Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Long-term Outcome in Elderly After Noncardiac Surgery
NCT03436472Completed
- Sponsor
- Peking University First Hospital
- Start
- Jun 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in postoperative delirium (POD) comparing Dexmedetomidine Group with Placebo Group (2 arms). Primary endpoint: Duration of 5-year survival after surgery. Started Jun 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT03436472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03436472.